Global Blood Therapeutics, Inc.: MHRA Grants Marketing Authorization for GBT's Oxbryta (voxelotor) for Use in Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older

Voxelotor is the first medicine approved in Great Britain to directly inhibit sickle hemoglobin (HbS) polymerization, the underlying molecular cause of sickle cell diseaseSOUTH SAN FRANCISCO, Calif., July

Related Keywords

Norway ,Iceland ,United States ,Liechtenstein ,United Kingdom ,Brazil ,Great Britain ,Informationfor Oxbryta ,Steven Immergut ,Courtney Roberts ,Kostenloser Wertpapierhandel ,Beatrizf Pujol ,Claudia Nabaie ,Diretrizes Terap ,National Institute Of Health ,Galien Foundation ,Health Qual Life Outcomes ,Intervention To Promote School Functioning For ,Blood Institute ,National Heart ,Scottish Medicines Consortium ,Centers For Disease ,Drug Administration ,Regulatory Agency ,Global Blood Therapeutics Inc ,Exchange Commission ,Sickle Cell Centers Clinical Trial Consortium ,Sickle Cell Society ,Brj Health Psychol ,Securities Exchange ,European Medicines Agency ,Blood Therapeutics ,National Institute ,Care Excellence ,Promising Innovative Medicinedesignation ,Early Access ,European Commissionearlier ,Lancet Haematologyin April ,European Economic Area ,Saharan Africa ,South Asian ,Southern European ,Middle Eastern ,Oxbryta Breakthrough Therapy ,Fast Track ,Orphan Drug ,Rare Pediatric Disease ,Galien United States ,Priority Medicinesand ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Quarterly Report ,About Sickle ,Accessed May ,Rev Dis ,Equal Life ,Learned From ,Randomized Controlled Trial ,Family Based Intervention ,Promote School Functioning ,School Age Children With Sickle Cell ,Comprehensive Sickle Cell Centers Clinical Trial ,Pediatr Blood ,Life Expectancy ,Disease Control ,Sickle Cell Disease Data ,Accessed June ,Sickle Cell ,Accessed February ,Global ,Flood ,Herapeutics ,Phra ,Migrants ,Marketing ,Authorization ,Xbryta ,Oxelotor ,Treat ,Britain ,Treatment ,Aemolytic ,Anemia ,Patients ,Pickle ,Fell ,Disease ,Tears ,Ilder ,